Join to View Full Profile
17087 Ryton LaneBoca Raton, FL 33496
Phone+1 404-798-7152
Dr. Lentnek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 1973 - 1975- University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
George Washington UniversityResidency, Internal Medicine, 1972 - 1973
University of ConnecticutResidency, Internal Medicine, 1969 - 1970
Hartford HospitalInternship, Transitional Year, 1968 - 1969
Tufts University School of MedicineClass of 1968
Certifications & Licensure
NY State Medical License 1971 - 2026
NJ State Medical License 1990 - 2025
GA State Medical License 1993 - 2021
CT State Medical License 1971 - 2016
PA State Medical License 1973 - 1994
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Teacher of the Year AOA, 2009
Clinical Trials
- Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 56 citationsA randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE studyMartin E. Stryjewski, Arnold Lentnek, William O'Riordan, John Pullman, Paul A. Tambyah
BMC Infectious Diseases. 2014-05-23 - 15 citationsTelavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.Martin E. Stryjewski, Steven L. Barriere, Ethan Rubinstein, Fredric C. Genter, Arnold Lentnek
International Journal of Antimicrobial Agents. 2013-10-01 - 7 citationsPrevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physici...Alexander J. Kallen, Susan E. Beekmann, Brandi Limbago, Arnold L. Lentnek, Philip M. Polgreen
Diagnostic Microbiology and Infectious Disease. 2011-11-01
Industry Relationships
- Consultant, Gerson Lehrman Group2010 - Present
- Consultant, Guidepoint Global2010 - Present
- Consultant, Senzar Capital Management2008 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
